CAS: 1445251-22-8
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
ME0328 REF: IN-DA00ASDACAS: 1445251-22-8 | 98% | 46.00 €~521.00 € | Tue 10 Dec 24 | |
ME0328 REF: TM-T6578CAS: 1445251-22-8 | 99.84% | 51.00 €~461.00 € | Mon 16 Dec 24 | |
3,4-Dihydro-4-oxo-N-[(1S)-1-phenylethyl]-2-quinazolinepropanamide REF: 3D-VHC25122CAS: 1445251-22-8 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00ASDA
1g | 521.00 € | ||
5mg | 46.00 € | ||
10mg | 56.00 € | ||
25mg | 74.00 € | ||
100mg | 135.00 € | ||
250mg | 200.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
ME0328
CAS:1445251-22-8
ME0328 is a potent and selective PARP inhibitor with IC50 of 0.89 μM for PARP3, …
Formula:
C19H19N3O2
Purity:
99.84%
Color and Shape:
Solid
Molecular weight:
321.37
Ref: TM-T6578
5mg | 51.00 € | ||
10mg | 72.00 € | ||
25mg | 143.00 € | ||
50mg | 260.00 € | ||
100mg | 461.00 € | ||
1mL*10mM (DMSO) | 53.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
3,4-Dihydro-4-oxo-N-[(1S)-1-phenylethyl]-2-quinazolinepropanamide
Controlled ProductCAS:1445251-22-8
Rifaximin, a non-absorbable antibiotic, is used to treat travelers' diarrhea and the irritable bowel syndrome. …
Formula:
C19H19N3O2
Purity:
Min. 95%
Molecular weight:
321.38 g/mol
Ref: 3D-VHC25122
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |